Annolyse
BriefingsCompaniesInsightsPrinciplesCompareWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology
  • Developers

© 2026 Annolyse. Analytical briefings for NZX company announcements.

Table of contents

  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material
←Back to briefings
Templeton Emerging Markets Investment Trust Plc (TEM) / HY23

Income up 72% but net assets fell 21% on capital losses

Stronger portfolio dividend receipts and a swing to net cash sit alongside a NZD 223.1m capital-return loss that drove equity sharply lower.

Release date
9 December 2022
Published
22 April 2026
Table of Contents⌄
  1. What changed
  2. What matters
  3. Expectations
  4. Quality of result
  5. Unresolved
  6. Key metrics
  7. Analytical metrics
  8. Metric context
  9. Reference material

What changed

Revenue (portfolio dividend income) rose 72.3% to NZD 55.7m from NZD 32.3m, and the revenue-return component of pre-tax profit was positive at NZD 52.4m. The headline result remained a loss because the capital return swung to NZD -223.1m, producing a PBT loss of NZD 170.7m (prior: NZD -185.2m) and an NPAT loss of NZD 177.3m (prior: NZD -191.9m). Operating cash inflow more than doubled to NZD 47.3m. Cash and equivalents rose to NZD 167.1m from NZD 40.7m, and with prior-period bank borrowings of NZD 100.5m no longer visible as a matching figure, the group moved from a net debt of roughly NZD 59.7m to a small net cash position of NZD 16.5m. Net equity fell 20.9% to NZD 1.9b, reflecting the capital losses on the investment portfolio.

What matters

  • The income line and the capital line are telling opposite stories. Dividend receipts from the portfolio expanded sharply, lifting the revenue return into clear profit, but a NZD 223.1m capital-return loss dominated the P&L and drove the NZD 494.3m decline in net equity. The operating read is improving; the NAV read is not.
  • Liquidity has moved decisively. Cash rose by NZD 126.4m and the balance sheet flipped to net cash. This is a meaningful de-risking versus the prior period's NZD 100.5m bank loan balance, though it also implies a higher idle-cash share of the portfolio at a time when the benchmark has been weak.
  • Receivable days improved to 26.8 from 44.2, consistent with the step-up in dividend income being actually collected in cash rather than accrued.

Expectations

No forward targets, guidance, or forward-work figures were supplied, and management commentary in the excerpts is macro-oriented (central banks, Ukraine) rather than quantitative. Against the FY22 anchor, annualised HY23 revenue of NZD 111.4m would be roughly double the NZD 54.3m full-year FY22 figure, but the prior-period shape data shows income is first-half weighted (HY22 was 59.6% of FY22 revenue), so a simple doubling overstates the likely full-year outcome. The release does not support any inference about whether the capital loss trajectory stabilises in the second half.

Quality of result

For an investment trust the durable component is the revenue return, and that has genuinely strengthened: dividend income up 72.3%, operating cash inflow up 102.7%, and receivable days cut nearly in half. Tax is immaterial (effective rate 3.9% versus 3.6%), so PBT and NPAT move together and there is no tax distortion to unwind. The reported loss, however, is overwhelmingly a mark-to-market outcome on the investment portfolio rather than an operating result, and the 20.9% decline in net equity is the more important signal on portfolio performance than the improvement in headline loss. Cash conversion is not a concern; the swing to net cash looks real rather than working-capital-assisted.

Unresolved

  • What drove the step-change in dividend income – underlying distributions from investees, portfolio rotation into higher-yielding names, or timing of receipts – is not disclosed in the supplied excerpts.
  • The fate of the NZD 100.5m prior-period bank loan is unclear from the data provided; whether it was repaid in full, refinanced, or simply not drawn at the balance date affects how the move to net cash should be interpreted.
  • No interim dividend amount is quantified in the supplied extraction, so the capital-allocation read is incomplete, as is any comparison to the FY22 ordinary dividend of 3.80p referenced in the anchor excerpts.
  • Portfolio concentration, sector/country exposure, and NAV per share are not in the supplied data, so relative performance versus the MSCI Emerging Markets benchmark cannot be assessed. This briefing cannot assess whether the portfolio is outperforming or underperforming its benchmark on a total-return basis.

Key metrics

← Swipe to view more
Key metrics table for Templeton Emerging Markets Investment Trust Plc HY23
Metric HY23 HY22 Change
Revenue $55.7m $32.3m +72.3% ↑
Net profit after tax −$177.3m −$191.9m +7.6% ↑
Net cash inflow from operating activities $47.3m $23.4m +102.7% ↑
Cash and cash equivalents $167.1m $40.7m +310.1% ↑
Total assets $1.9b $2.4b -20.9% ↓

Analytical metrics

← Swipe to view more
Analytical metrics table for Templeton Emerging Markets Investment Trust Plc HY23
Metric HY23 HY22 Context
Debtor days 26.8 44.2 -17.4 days
Trade debtors $8.2m $7.9m +$0.34m
Net debt −$16.5m $59.7m −$76.3m
Gross borrowings — $100.5m —
ROE (annualised) -16.7% -17.2% Strengthening
HY22 share of FY22 revenue 59.6% — Other half was 40.4%
HY22 share of FY22 NPAT 43.4% — Other half was 56.6%

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.

Source-backed analysis from the filing set attached to this briefing.

Metric context

Trajectory before this result

A compact view of the company's recent revenue and margin path, derived from the same metrics history that powers the company page.

TEM revenue trajectory

Revenue context before the current result.

← Swipe to view more
TEM revenue trajectory preview table
PeriodTEM
HY24$38.3m
HY23$55.7m
FY22$54.3m
HY22$32.3m
FY21$59.9m

TEM EBITDA margin

Earnings margin across covered periods.

← Swipe to view more
TEM EBITDA margin preview table
PeriodTEM
HY24n/a
HY23-303.2%
FY22-792.1%
HY22-568.8%
FY21n/a

Appendix

Reference material

Company materials considered in this briefing.

Current period

Statement of Half-Yearly Results to 30 Sept 22

HY23 / financial report↗

Prior comparable period

Half-year Report

HY22 / financial report↗

Full-year context

Statement of Annual Results to 31 March 2021

FY22 / financial report↗

Related insight

See how earnings quality compares across covered companies

→

Email updates

Want briefings like this for the next reporting season?

Get the next Annolyse briefing by email when it is published.

TEM revenue trajectory

Revenue context before the current result.

TEM EBITDA margin

Earnings margin across covered periods.